Functional polymorphism of cyclooxygenase-2 gene (G-765C) in chronic obstructive pulmonary disease patients

Molecular Biology Reports

Volumn 39, Issue 3, 2012, Pages 2163-2167

  Pietras, Tadeusz ^a   Szemraj, Janusz ^a   Panek, Michał ^a   Witusik, Andrzej ^a   Banasiak, MacIej ^a,c   Antczak, Adam ^a,b   Górski, Paweł ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Jan Kochanowski Memorial University of Humanities and Sciences   (Poland)

^c 90 329   (Poland)

Author keywords

Chronic obstructive pulmonary disease; Cyclooxygenase 2; Single nucleotide polymorphism

Indexed keywords

AGED; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

CYCLOOXYGENASE 2; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

NICOTIANA TABACUM;

EID: 84863827124     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0964-2     Document Type: Article

References (37)

1. Rouzer CA, Marnett LJ (2009) Cyclooxygenases: structural and functional insights. J Lipid Res 50:S29-S34
2. Murat N, Hocaoglu N, Karatosun V, Yorukoglu K, Gidener S, Gunal I (2005) The effects of non-selective and cyclooxygenase- 2-selective non-steroidal anti-inflammatory drugs on heterotopic ossification in rats. Med Sci Monit 11:BR449-BR451
3. Minghetti L (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63:901-910
4. Chakraborti AK, Garg SK, Kumar R, Motiwala HF, Jadhavar PS (2010) Progress in COX-2 inhibitors: a journey so far. Curr Med Chem 17:1563-1593
5. Lee KS, Lee HJ, Ahn KS, Kim SH, Nam D, Kim DK, Choi DY, Ahn KS, Lu J, Kim SH (2009) Cyclooxygenase-2/prostaglandin E2 pathway mediates Icariside II induced apoptosis in human PC- 3 prostate cancer cells. Cancer Lett 280:93-100
6. Gryglewski RJ, Chłopicki S, Uracz W, Marcinkiewicz E (2001) Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Med Sci Monit 7:1-16
7. Abdullah L, Ait-Ghezala G, Crawford F, Crowell TA, Barker WW, Duara R, Mullan M (2006) The cyclooxygenase 2-765 C promoter allele is a protective factor for Alzheimer's disease. Neurosci Lett 395:240-243
8. Listì F, Caruso C, Lio D, Colonna-Romano G, Chiappelli M, Licastro F, Candore G (2010) Role of cyclooxygenase-2 and 5-lipoxygenase polymorphisms in Alzheimer's disease in a population from northern Italy: implication for pharmacogenomics. J Alzheimers Dis 19:551-557
9. Gałecki P, Florkowski A, Bieńkiewicz M, Szemraj J (2010) Functional polymorphism of cyclooxygenase-2 gene (G-765C) in depressive patients. Neuropsychobiology 62:116-120
10. Zhao D, Xu D, Zhang X, Wang L, Tan W, Guo Y, Yu D, Li H, Zhao P, Lin D (2009) Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin. Gastroenterology 136:1659-1668
11. Gao J, Ke Q, Ma HX, Wang Y, Zhou Y, Hu ZB, Zhai XJ, Wang XC, Qing JW, Chen WS, Jin GF, Liu JY, Tan YF, Wang XR, Shen HB (2007) Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population. J Toxicol Environ Health A 70:908-915
12. Lee KH, Kim HS, El-Sohemy A, Cornelis MC, Uhm WS, Bae SC (2006) Cyclooxygenase-2 genotype and rheumatoid arthritis. J Rheumatol 33:1231-1234
13. Ke-Xiang Z, Yu-Min L, Xun L, Wen-Ce Z, Yong S, Tao L (2011) Study on the association of COX-2 genetic polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu province in China. Mol Biol Rep 38:649-655
14. Ben Nasr H, Chahed K, Bouaouina N, Chouchane L (2009) PTGS2 (COX-2) -765 G[C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma. Mol Biol Rep 36:193-200
15. Zhu W, Wei BB, Shan X, Liu P (2010) 765G[C and 8473T[C polymorphisms of COX-2 and cancer risk: a metaanalysis based on 33 case-control studies. Mol Biol Rep 37: 277-288
16. Güler VG, Yalin S, Berköz M, Cimen OB, Yalin E, Eroǧlu P, Kanik A (2011) The association between cyclooxygenase-2 (COX-2/PTGS2) gene polymorphism and osteoarthritis. Eklem Hastalik Cerrahisi 22:22-27
17. de Vries HS, te Morsche RH, van Oijen MG, Nagtegaal ID, Peters WH, de Jong DJ (2010) The functional -765G ? C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease. PLoS One 5:e15011
18. Shi J, Misso NL, Duffy DL, Thompson PJ, Kedda MA (2004) A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population. Clin Exp Allergy 34:1714-1718
19. Dong J, Dai J, Zhang M, Hu Z, Shen H (2010) Potentially functional COX-2-1195G[A polymorphism increases the risk of digestive system cancers: a meta-analysis. J Gastroenterol Hepatol 25:1042-1050
20. Profita M, Sala A, Bonanno A, Riccobono L, Ferraro M, La Grutta S, Albano GD, Montalbano AM, Gjomarkaj M (2010) Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products. Am J Physiol Lung Cell Mol Physiol 298:L261-L269
21. Vassallo R, Kroening PR, Parambil J, Kita H (2008) Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses. Mol Immunol 45:3321-3329
22. Cornwell WD, Kim V, Song C, Rogers TJ (2010) Pathogenesis of inflammation and repair in advanced COPD. Semin Respir Crit Care Med 31:257-266
23. Bland JM, Altman DG (2000) Statistics notes: the odds ratio. BMJ 320:1468
24. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, Bird TD, Schellenberg GD (1995) A familial Alzheimer's disease locus on chromosome 1. Science 269:970-973
25. Kim V, Rogers TJ, Criner GJ (2008) New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:478-485
26. Maher SA, Birrell MA, Belvisi MG (2009) Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy. Am J Respir Crit Care Med 180:923-928
27. Csanky E, Rühl R, Scholtz B, Vasko A, Takacs L, Hempel WM (2009) Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls. Electrophoresis 30:1228-1234
28. Coskunpinar E, Eraltan IY, Turna A, Agachan B (2010) Cyclooxygenase- 2 gene and lung carcinoma risk. Med Oncol. doi: 10.1007/s12032-010-9627-8
29. Terzano C, Conti V, Di Stefano F, Petroianni A, Ceccarelli D, Graziani E, Mariotta S, Ricci A, Vitarelli A, Puglisi G, De Vito C, Villari P, Allegra L (2010) Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung 188: 321-329
30. Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, Goldstein AM, Chaturvedi AK, Wacholder S, Landi MT, Lubin JH, Caporaso NE (2009) Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One 4:e7380
31. Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, Laurent GJ (2002) Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 22:1631-1636
32. Montuschi P, Macagno F, Parente P, Valente S, Lauriola L, Ciappi G, Kharitonov SA, Barnes PJ, Ciabattoni G (2005) Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. Thorax 60:827-833
33. Couillard A, Muir JF, Veale D (2010) COPD recent findings: impact on clinical practice. COPD 7:204-213
34. van Zyl Smit RN, Pai M, Yew WW, Leung CC, Zumla A, Bateman ED, Dheda K (2010) Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J 35:27-33
35. Wouters EF, Reynaert NL, Dentener MA, Vernooy JH (2009) Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc Am Thorac Soc 6:638-647
36. Magnussen H, Watz H (2009) Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities. Proc Am Thorac Soc 6:648-651
37. Barnes PJ (2009) The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 41:631-638